Price change (24h):
0.08%
High (24h):
$31.87
Low (24h):
$30.86
Volume (24h):
$495.99
Market Cap:
$322.22K
All Time High:
5.47% $32.92
Jul 2, 2026
All Time Low:
182% $11.05
Mar 27, 2026
0.00 %(1Y)
$31.67
Price change (24h):
0.08%
High (24h):
$31.87
Low (24h):
$30.86
Volume (24h):
$495.99
Market Cap:
$322.22K
All Time High:
5.47% $32.92
Jul 2, 2026
All Time Low:
182% $11.05
Mar 27, 2026
Oscar Health Tokenized Stock (Ondo) (OSCRon) is a cryptocurrency that tokenizes equity exposure to Oscar Health, Inc., a publicly traded health insurance company. The asset functions as a real-world asset (RWA) and tokenized stock, issued through Ondo Finance’s infrastructure that bridges traditional capital markets with decentralized protocol layers. Its existence turns a regulated New York Stock Exchange listing into a programmable token capable of circulating across permissionless liquidity venues.
The core utility strips away broker-mediated settlement cycles and fixed trading windows. OSCRon allows continuous, discretionary price discovery against stablecoins and crypto-native pairs on automated market makers. Because the token wraps a fractional claim on underlying shares held in custody, it lets capital rotate into equities without navigating legacy gatekeepers, clearinghouses, or geographic restrictions.
Oscar Health Tokenized Stock (Ondo) operates on the Ethereum, BNB Chain, and Solana networks. Each deployment leverages that blockchain’s native contract environment, anchoring the same economic exposure in three distinct liquidity ecosystems simultaneously. The multi-chain footprint means the asset absorbs the security assumptions of Ethereum, the lower-cost execution of BNB Smart Chain, and Solana’s high-throughput settlement layer.
Every chain-specific instance conforms to its respective token standard—ERC-20 on Ethereum, BEP-20 on BSC, and SPL on Solana—so that decentralized exchanges can ingest OSCRon without proprietary bridging middleware. Smart contract addresses verified across Etherscan, BscScan, and Solana explorers make the supply auditable. Native integration with each chain’s wallet infrastructure lets institutions and individuals custody the token inside self-sovereign, on-chain portfolios.
The tokenized stock emerged from Ondo Finance’s broader push into on-chain equities, a category that mints representations of publicly listed firms. Ondo Finance, the issuer protocol, coordinates the off-chain custody, minting, and burning flows. While no single launch year punctuates the Oscar Health-specific token, it arrived as part of a suite of tokenized securities designed to furnish DeFi with direct, composable equity primitives that respect regulatory perimeter guidelines.
The long-term objective centers on collapsing the distance between isolated national stock exchanges and the globally accessible, always-on capital pools of decentralized finance. Encoding equity ownership into a blockchain-native wrapper creates a censorship-resistant vehicle for price exposure that operates beyond banking hours and intermediate clearinghouses. It substitutes the complexity of cross-border broker accounts with a wallet address and an internet connection, expanding equity access to a planetary scale without a corresponding expansion of intermediary risk.
At the mechanical level, OSCRon tokens do not embed governance voting or direct dividend rights. Instead, each token serves as a verifiable on-chain claim that tracks the market price of an Oscar Health share fraction, enabling its utility as a settlement asset inside DeFi. The token plugs into lending pools, portfolio rebalancing strategies, and collateralized debt positions, functioning purely as a programmable exposure vector that settles atomically on the blockchain.
Market participants can deposit OSCRon into money markets as collateral to borrow stablecoins, preserving upside while accessing liquidity. Liquidity providers on decentralized exchanges supply tokens to earn swap fees from round-the-clock trading activity. Because the token lives on three distinct chains, holders route transactions through the network offering the lowest execution cost at any given moment, optimizing capital efficiency without sacrificing custody control.
Oscar Health Tokenized Stock (Ondo) has a total supply of 416.26 tokens. Currently, 416.26 tokens are in circulation. With a market capitalization of $7,002.43, Oscar Health Tokenized Stock (Ondo) ranks #10,533 among all cryptocurrencies.
| Date | Open | Close | High | Low |
|---|---|---|---|---|
| 08/07/2026 | $31.09 | $31.09 | $31.10 | $31.09 |
| 07/07/2026 | $31.41 | $31.06 | $32.24 | $31.06 |
| 06/07/2026 | $31.63 | $31.37 | $31.77 | $30.79 |
| 04/07/2026 | $32.13 | $32.13 | $32.13 | $32.13 |
| 03/07/2026 | $32.14 | $32.13 | $32.14 | $32.13 |
| 02/07/2026 | $31.86 | $31.93 | $32.92 | $31.75 |
| 01/07/2026 | $29.29 | $31.52 | $31.92 | $29.29 |
AI trades 24/7 automatically Catch every opportunity
Zero-emotion algorithm Disciplined strategy
Passive income Set & forget automation
20,000+
traders trusted Stoic AI
$200M+
in cumulative assets under management since inception
2015
year of company foundation
Disclaimer:
This website is operated by Cindicator Ltd. (“Cindicator”), a Gibraltar private company. You are solely responsible for compliance with all laws that may apply to you and your use of Cindicator products. Cryptocurrencies and blockchain technologies have been the subject of scrutiny by regulatory bodies worldwide. With respect to your use of Cindicator products, Cindicator makes no representations regarding the applicability or compliance of its products with any laws or regulations, including, without limitation, those related to trading, options, derivatives, or securities. You also assume all legal, economic, and other risks related to your use of Cindicator products, including legal uncertainty, market volatility, and information security risks, among others. Trading in cryptocurrencies and digital assets is highly speculative, and the value of investments can fluctuate dramatically. You may lose a substantial portion or even all of your invested capital, and such trading may not be suitable for everyone. If you are unsure about these risks or your ability to bear potential losses, you should consult with an independent financial advisor before using Cindicator products. Depending on your jurisdiction, access to or use of Cindicator products may be subject to certain legal restrictions or prohibitions. You agree that it is solely your responsibility to determine and comply with any laws and regulations applicable to your use of Cindicator products, and that Cindicator is not responsible for informing you of such requirements.
Cindicator reserves the right to restrict or refuse access to its products for citizens or residents of certain jurisdictions, including those subject to international sanctions or other legal restrictions. All materials provided on this website (including any graphical materials regarding trading strategy performance or P&L) are presented solely for marketing and informational purposes. They do not guarantee any future profits and should not be construed as financial, investment, legal, or other professional advice. Cindicator is not a registered broker-dealer, investment adviser, or regulated financial institution, and the information and services provided do not constitute personal investment advice or a recommendation or offer to buy or sell any securities, cryptocurrencies, or other financial instruments. The information provided herein is summary in nature, does not purport to be complete, and is provided “as is” without any warranty as to its accuracy or completeness. All content may be updated or changed at any time without notice. Past performance is not indicative of future results. To the maximum extent permitted by law, Cindicator (including its directors, officers, and affiliates) shall not be liable for any loss or damage (direct, indirect, special, consequential, or incidental) arising from your use of Cindicator products, this website, or any information contained herein. Please read our Terms of Use for further details. If you do not agree with these terms, please close this site.